Rehovot, Israel

Rina Yamin

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 12(Granted Patents)


Location History:

  • Rehovot, IL (2011 - 2016)
  • Ganne Yohannan, IL (2017)

Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Rina Yamin: Innovator in Alcohol Consumption Solutions

Introduction

Rina Yamin is a notable inventor based in Rehovot, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in developing methods to alleviate the symptoms associated with alcohol consumption. With a total of 6 patents to her name, Yamin's work is paving the way for innovative solutions in this area.

Latest Patents

Among her latest patents is a method for decreasing symptoms of alcohol consumption. This invention relates to methods and compositions of metadoxine and its physiologically compatible active derivatives. It aims to reduce symptoms of alcohol consumption and prevent related issues in individuals who require assistance. Another significant patent is for substituted pyridoxine-lactam carboxylate-salts. This invention provides salt adducts that include a positively charged moiety, such as pyridoxine or its derivatives, and a carboxylated lactam ring. These compositions can be utilized in treating diseases or disorders linked to alcohol consumption.

Career Highlights

Rina Yamin has worked with various companies, including Alcobra Ltd. and Cts Chemical Industries, Ltd. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations.

Collaborations

Yamin has collaborated with notable professionals in her field, including Dalia Megiddo and Yaron Ilan. These partnerships have enhanced her research and development efforts.

Conclusion

Rina Yamin's innovative work in developing solutions for alcohol consumption symptoms showcases her dedication to improving health outcomes. Her patents reflect a commitment to advancing pharmaceutical science and addressing critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…